STOCK TITAN
  1. Home
  2. Sec-filings
  3. THC
  4. [Form 4] TENET HEALTHCARE CORP Insider Trading Activity

Tenet Healthcare (NYSE: THC) CEO details RSU vesting and share withholding

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Tenet Healthcare Corp reported an insider equity transaction by CEO and director Saumya Sutaria. On December 31, 2025, 13,016 restricted stock units converted into common stock on a one-for-one basis, increasing his directly held stake.

On the same date, 6,610 shares of common stock were withheld to cover taxes at a price of $198.72 per share. After these transactions, Sutaria directly owned 375,089 shares of Tenet common stock and held 39,049 time-based restricted stock units that continue to vest annually through 2028 under a January 23, 2025 grant.

Positive

  • None.

Negative

  • None.
Insider Sutaria Saumya
Role CEO
Type Security Shares Price Value
Exercise 2025 January Restricted Stock Units 13,016 $0.00 --
Exercise Common Stock 13,016 $0.00 --
Tax Withholding Common Stock 6,610 $198.72 $1.31M
Holdings After Transaction: 2025 January Restricted Stock Units — 39,049 shares (Direct); Common Stock — 381,699 shares (Direct)
Footnotes (1)
  1. Restricted stock units convert into common stock on a one-for-one basis. Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Represents the closing price of the common stock of the Issuer on December 31, 2025. The restricted stock units were granted on January 23, 2025, pursuant to the 2019 Stock Incentive Plan, vest equally in 1/4 increments on December 31, 2025, 2026, 2027 and 2028, and the first 1/4 increment vested on December 31, 2025. Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sutaria Saumya
(Last) (First) (Middle)
14201 DALLAS PARKWAY
(Street)
DALLAS TX 75254
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
CEO
3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/31/2025 M 13,016 A (1) 381,699 D
Common Stock 12/31/2025 F 6,610(2) D $198.72(3) 375,089 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
2025 January Restricted Stock Units (4) 12/31/2025 M 13,016 (4) (4) Common Stock(5) 13,016 $0 39,049 D
Explanation of Responses:
1. Restricted stock units convert into common stock on a one-for-one basis.
2. Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
3. Represents the closing price of the common stock of the Issuer on December 31, 2025.
4. The restricted stock units were granted on January 23, 2025, pursuant to the 2019 Stock Incentive Plan, vest equally in 1/4 increments on December 31, 2025, 2026, 2027 and 2028, and the first 1/4 increment vested on December 31, 2025.
5. Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.
Chad J. Wiener, as Attorney-in-fact for Saumya Sutaria 01/02/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Tenet Healthcare (THC) report in this filing?

The filing reports that CEO and director Saumya Sutaria had 13,016 restricted stock units convert into Tenet Healthcare common stock on December 31, 2025, with a portion of the resulting shares withheld to cover taxes.

How many Tenet Healthcare (THC) shares were acquired and withheld for taxes?

Sutaria acquired 13,016 shares of Tenet Healthcare common stock from vested restricted stock units and had 6,610 shares withheld to satisfy tax obligations at a price of $198.72 per share.

What is Saumya Sutaria’s role at Tenet Healthcare (THC)?

Saumya Sutaria is reported as both a Director and an Officer of Tenet Healthcare Corp, serving as CEO in this filing.

How many Tenet Healthcare (THC) shares does the CEO own after this transaction?

Following the reported transactions, Sutaria directly owned 375,089 shares of Tenet Healthcare common stock.

What restricted stock unit grants are still outstanding for the Tenet Healthcare CEO?

After the December 31, 2025 vesting, Sutaria held 39,049 time-based restricted stock units that are scheduled to settle in Tenet Healthcare common stock upon future vesting dates.

What is the vesting schedule of the January 2025 restricted stock units at Tenet Healthcare (THC)?

The restricted stock units granted on January 23, 2025 under Tenet’s 2019 Stock Incentive Plan vest in four equal annual installments on December 31 of 2025, 2026, 2027 and 2028. The first 1/4 tranche vested on December 31, 2025.